Your session is about to expire
← Back to Search
Study Summary
This trial studies the safety of a new drug for people with narcolepsy, a sleep disorder.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a stroke or mini-stroke in the last 5 years.I have a history of significant heart problems.I am currently experiencing or have recently had a major depressive episode.I take medication for a condition like heart disease or anxiety that is not allowed in the study.I have had a stomach or intestine problem in the last 6 months that could affect how my body absorbs medication.I had a moderate or severe side effect from the study drug in the previous study.I have had cancer within the last 5 years, excluding minor skin cancers or resolved in situ carcinomas.I have narcolepsy, finished a TAK-861 study, and my doctor agrees I can join.I have a condition causing excessive daytime sleepiness, not just narcolepsy.I have epilepsy or a history of seizures.
- Group 1: TAK-861 Dose 1
- Group 2: TAK-861 Dose 2
- Group 3: TAK-861 Dose 3
- Group 4: TAK-861 Dose 4
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment open to participants aged 50 or above?
"This medical trial requires that enrollees be between 16 and 70 years of age. There are 11 studies available for minors, while 18 separate trials can be accessed by those over 65."
What criteria must patients meet in order to be eligible for this medical experiment?
"Candidates with narcolepsy who are between 16 and 70 years old may be accepted into this trial. The recruitment process targets 160 participants in total."
What is the largest population of participants in this medical study?
"Affirmative. Per the clinicaltrials.gov entry, recruitment for this medical study is ongoing; it was initially posted on April 5th 2023 and last modified a few weeks later on the 21st of April. 160 patients are needed at 1 trial site to complete enrolment."
Are there any spaces available for those who wish to join this trial?
"Affirmative, clinicaltrials.gov data indicates that this medical trial has resumed recruitment efforts since its original posting on April 5th 2023. The last update was done on April 21st 2023 and the researchers are seeking 160 volunteers across a single site."
Share this study with friends
Copy Link
Messenger